DALLAS (September 21, 2021)—Medalogix, a health-tech company using machine learning to advance patient care within home health, palliative and hospice care settings, has partnered with Homecare Homebase (HCHB) to announce Heart to Heart Hospice as the winner of the Medalogix Muse Trailblazer Award. The award is presented annually to organizations that leverage Medalogix Muse technology to achieve the highest quality of patient care.
Chief Information Officer, Russ Abercrombie of Heart to Heart, noted the importance of the Medalogix Muse product to their team. “Muse allows Heart to Heart clinicians to make the most of the vast amount of accumulated data stored in the HCHB EMR software. Muse gathers, analyzes, and presents the data in a concise intuitive format that empowers the team to provide the high-quality care that Heart to Heart Hospice in known for,” said Abercrombie.
The Medalogix team reviewed all customers that currently use its Medalogix Muse product. The selection committee reviewed each customer’s level of product adoption, user feedback and contribution to the evolution of the product, and the number of patients impacted by the product relative to the customer’s census. Heart to Heart was noted as being an exceptional candidate for the award, as they provide quality care for their patients enhanced by the power of Medalogix’s machine-learning technology, and have contributed multiple ideas to Medalogix to improve the user experience of the product.
Heart to Heart leverages Medalogix Muse, which is integrated with Heart to Heart’s EMR, HCHB. The product identifies which hospice patients are most likely to transition within seven to 10 days, by analyzing more than 800 assessment points from numerous visits from the system. “The solution offered by HCHB and Medalogix continues to drive value to the industry,” said Scott Pattillo, chief strategy officer at HCHB. “The partnership between Medalogix and Heart to Heart is encouraging to see and patients remain the true benefactors of the relationship.”
Medalogix Muse is currently being leveraged to monitor the status of more than 60,000 hospice patients each day. “Muse is an incredibly powerful product and does an amazing job identifying patients on hospice who are about to transition,” said President and CEO of Medalogix, Elliott Wood. “What is most important, however, is the successful adoption of these products by clinicians, who create true impact for patients and their families at the end of life. We are proud to partner with Heart to Heart, and excited to see the difference they are making in the lives of their patients by delivering exceptional care at the right time.”
Visit hearttohearthospice.com, medalogix.com, and hchb.com for more information.
